EDIT vs PNC · rev $32.3M vs P/E 14, rev $23.10B
Editas Medicine Inc (EDIT) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
EDIT currently screens at market cap $375.2M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the EDIT and PNC stock pages for the full models.
Not investment advice.